Skip to main content

Table 4 Volume change between initial and repeat scan for intracerebral and/or intraventricular bleed subpopulation after propensity score-overlap weighting

From: Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis

 

Andexanet alfa

n = 47

4F-PCC

n = 37

Initial volume (mL), mean ± SD

7.29 ± 9.82

7.29 ± 9.05

Repeat volume (mL), mean ± SD

8.12 ± 12.28

12.02 ± 16.82

Change in volume (mL), mean ± SD

0.83 ± 4.25

4.73 ± 12.10

Weighted difference in mean volume change (mL), 4F-PCC referent (95% CI)

− 3.90 (− 10.81 to 3.00)

 
  1. CI = confidence interval, 4F-PCC = four-factor prothrombin complex concentrate, SD = standard deviation